Optiscan has been featured in Stockhead's Long Shortz where Optiscan CEO Dr. Camile Farah spoke with Tylah Tully to discuss the US launch of the InSpecta veterinary imaging device, the commercial opportunity in the veterinary market, and why this marks a major milestone as the company prepares additional FDA submissions for its human healthcare platforms.

Dr. Farah outlines the impact InSpecta can have on veterinary medicine, and the significant opportunity that exists.

Watch the full episode here.